Breast Imaging

Women's health news related to breast imaging, including mammography, breast MRI, automated breast ultrasound (ABUS), breast ultrasound, breast biopsy, and positron emission mammography (PEM). This channel also includes news on breast density and the issues it causes in detecting cancers.  Mammography can be broken into two types of systems. 2-D full field digital mammography (FFDM) have almost completely replaced older X-ray film based systems. The newest generation systems use 3-D tomosynthesis mammography technology, where a series of digital images are shot in an arch around the breasts and a computer reconstructs the images into slices that can be scrolled through to see layers of tissue. This allows easier radiology reading of images, especially in women with dense breasts, because it can cancers where there are several layers of thick breast tissue that can mask cancers on 2-D mammography. Tomo is rapidly replacing FFDM.

Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
Registration Now Open for RSNA21
July 21, 2021 — Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly...
read more
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
Routine Screening Return for BI-RADS 3 Lesions on Supplemental Automated Whole-Breast Ultrasound
July 16, 2021 —According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3...
read more
Volpara now holds 98 granted patents across 27 countries
News | Breast Imaging | July 16, 2021
Volpara Health Grows its Patent Collection
July 16, 2021 — Volpara has recently been granted another patent by the European Patent Office, raising the total...
read more
Interviews with the 1,000 at-risk patients also led to some interesting conclusions, Fine said. Even in the early days of 3D mammography, most women interviewed had at least heard about the technology.

Getty Images

News | Mammography | July 15, 2021
Study of 3D Mammography Shows Fewer Callbacks for New Mexican Women
July 15, 2021 —  For any type of diagnostic test, technology that helps improve the reliability of test results is a...
read more
Serena Bright sets new standards for breast cancer detection and biopsy technology
News | Breast Biopsy Systems | July 07, 2021
GE Healthcare’s Industry-First Contrast-Guided Biopsy Solution, Serena Bright, Installed in Five Major Hospitals in the United States
July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around...
read more
A new study set out to learn more about breast health for Black women and to establish a better understanding of the breast screening landscape by analyzing mammograms, screening intervals and interpretation performance for Asian, Black and white women across health systems throughout the United States, with participation from Advocate Health Care, Sanford Health and the University of Pennsylvania Health System.

Getty Images

Feature | Breast Imaging | July 06, 2021 | By Linda Goler Blount, MPH
Black Women Are Receiving Inferior Breast Screening
It is well established that there are racial disparities in healthcare that can have devastating implications for...
read more
Due to dangerous implications for years to come, facilities must increase efficiency and capacity for breast cancer care to recover from the impact of COVID-19

Getty Images

Feature | Breast Imaging | July 06, 2021 | By Ananth Ravi, Ph.D.
The Backlog in Breast Cancer Care
The challenges faced by hospitals during the COVID-19 pandemic have severely impacted cancer care. While the...
read more
Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding nonmelanoma skin cancer. Additionally, the National Cancer Institute recently predicted an almost 10,000 excess deaths from breast and colorectal cancers over the next 10 years as a direct result of the pandemic, making it now more important than ever for women to take control over their breast health.
News | Artificial Intelligence | June 25, 2021
How AI is Helping the Fight Against Breast Cancer
June 25, 2021 — Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding...
read more
According to a new study, by the Harvey L. Neiman Health Policy Institute and the American College of Radiology’s National Mammography Database Committee, the most influential radiologist characteristics impacting mammography interpretive performance were geography, breast sub-specialization, performance of diagnostic mammography, and performance of diagnostic ultrasound.

Getty Images

News | Breast Imaging | June 23, 2021
Study Finds Radiologist Characteristics Predict Performance in Screening Mammography
June 23, 2021 — According to a new study, by the Harvey L. Neiman Health Policy Institute and the American College of...
read more
New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines call for heightened screening attention for transgender individuals, Black women and other often overlooked or underserved populations.

Getty Images

News | Breast Imaging | June 22, 2021
New ACR/SBI Breast Cancer Screening Guidelines Address Heightened Risk for LGBTQ Persons and Black Women
June 22, 2021 — New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening...
read more
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, according to a new JAMA Oncology study of nearly 30,000 patients led by researchers in the Basser Center for BRCA at the Abramson Cancer Center.

Getty Images

News | Women's Health | June 15, 2021
Black and White Women Have Same Mutations Linked to Breast Cancer Risk
June 15, 2021 — The prevalence of genetic mutations associated with breast cancer in Black and white women is the same...
read more
Kathryn A. Gold, M.D., associate clinical professor at University of California San Diego School of Medicine, presented data showing an increase in people diagnosed with advanced stage breast cancer in 2020 and 2021, compared to 2019.

Kathryn A. Gold, M.D., associate clinical professor at University of California San Diego School of Medicine, presented data showing an increase in people diagnosed with advanced stage breast cancer in 2020 and 2021, compared to 2019.

News | Breast Imaging | June 08, 2021
Increase in Advanced Breast Cancer Diagnoses During COVID-19 Pandemic
June 8, 2021 — Reporting at the 2021 annual meeting of the American Society of Clinical Oncology, Kathryn A. Gold, M.D...
read more
The Radiological Society of North American announced that RSNA21 will be back — live — this November in Chicago
News | RSNA | May 17, 2021
RSNA Annual Meeting Returns to Chicago in 2021
May 17, 2021 — The Radiological Society of North America (RSNA) announced today that 10,378 scientific and educational...
read more
Medical researchers at Flinders University have established a new link between high body mass index (BMI) and breast cancer survival rates — with clinical data revealing worse outcomes for early breast cancer (EBC) patients and improved survival rates in advanced breast cancer (ABC).

Getty Images

News | Women's Health | May 13, 2021
Decoding the Effect of Body Mass Index on Breast Cancer
May 13, 2021 — Medical researchers at Flinders University have established a new link between high body mass index (BMI...
read more
Hologic, Inc. launched Project Health Equality (PHE), a unique initiative that strives to address the structural and cultural barriers that prevent Black and Hispanic women in the U.S. from receiving the same quality health care as white women.
News | Women's Health | May 12, 2021
Hologic Launches $20M Initiative to Tackle Racial Disparities in Healthcare
May 12, 2021 — Hologic, Inc. launched Project Health Equality (PHE), a unique initiative that strives to address the...
read more
Videos | Coronavirus (COVID-19) | May 11, 2021
VIDEO: COVID Vaccine Adenopathy Can Last Up to 10 Weeks
Yael Eshet, M.D., MSc, a diagnostic radiology specialist at Sheba Medical Center in Israel, was the lead author on a...
read more
News | Artificial Intelligence | May 11, 2021
Breast Cancer AI Company Whiterabbit Receives FDA Clearance for WRDensity
May 11, 2021 — Whiterabbit, an AI technology company focused on early breast cancer detection, today announced the...
read more
A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer.
News | Radiation Therapy | May 11, 2021
New Marker Predicts Benefit of Radiotherapy for Early-stage Breast Cancer
May 11, 2021 —A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that...
read more
GE Healthcare announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized healthcare. The company aims to develop and bring to market Zionexa’s pipeline biomarkers, as well as the recently FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18)
News | PET Imaging | May 06, 2021
GE Healthcare Acquires Zionexa
May 6, 2021 — GE Healthcare announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology...
read more
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | May 03, 2021 | By Dave Fornell, Editor
COVID-19 Vaccine Can Cause False Positive Cancer Diagnosis
While the mass COVID-19 vaccination effort over the past four months is bringing closer the light at the end of the...
read more
© Copyright Wainscot Media. All Rights Reserved.